DANSEY ROGER D
SEC insider (Form 3/4/5 filer). CIK 0001741836. Director at INOVIO PHARMACEUTICALS, INC. (INO) and 3 other issuers. 10 reported Form 4/5 transactions since Sep 2024; latest on May 20, 2026. Located in CAMBRIDGE, X0.
Companies DANSEY ROGER D has filed insider reports for
- INOVIO PHARMACEUTICALS, INC. (INO): Director
- Nurix Therapeutics, Inc. (NRIX): Director
- BICYCLE THERAPEUTICS PLC (BCYC): Director
- Kronos Bio, Inc. (KRON): Director
DANSEY ROGER D
CIK: 0001741836
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- May 20, 2026INO
INOVIO PHARMACEUTICALS, INC.
AwardDirectCommon Stock Options
41.8K shares- - May 20, 2026INO
INOVIO PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Unit
34.2K shares- - May 15, 2026NRIX
Nurix Therapeutics, Inc.
AwardDirectDirector Stock Option (right to buy)
31.3K shares- - Jan 2, 2026BCYC
BICYCLE THERAPEUTICS PLC
AwardDirect3K shares- - Nov 6, 2025NRIX
Nurix Therapeutics, Inc.
AwardDirectDirector Stock Option (right to buy)
50K shares- - Sep 8, 2025BCYC
BICYCLE THERAPEUTICS PLC
AwardDirect12.5K shares- - Jun 20, 2025KRON
Kronos Bio, Inc.
DispositionDirectStock Option (Right to Buy)
68K shares- - Jun 20, 2025KRON
Kronos Bio, Inc.
DispositionDirectStock Option (Right to Buy)
5.9K shares- - Jun 20, 2025KRON
Kronos Bio, Inc.
DispositionDirectStock Option (Right to Buy)
34K shares- - May 21, 2025INO
INOVIO PHARMACEUTICALS, INC.
ExerciseDirect2.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 20, 2026 |  INO INOVIO PHARMACEUTICALS, INC. | Award Common Stock Options | 41,800 | - | - | Direct |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Award Restricted Stock Unit | 34,200 | - | - | Direct |
| May 15, 2026 |  NRIX Nurix Therapeutics, Inc. | Award Director Stock Option (right to buy) | 31,250 | - | - | Direct |
| Jan 2, 2026 |  BCYC BICYCLE THERAPEUTICS PLC | Award | 3,032 | - | $0 | Direct |
| Nov 6, 2025 | NRIX Nurix Therapeutics, Inc. | Award Director Stock Option (right to buy) | 50,000 | - | - | Direct |
| Sep 8, 2025 | BCYC BICYCLE THERAPEUTICS PLC | Award | 12,500 | - | - | Direct |
| Jun 20, 2025 |  KRON Kronos Bio, Inc. | Disposition Stock Option (Right to Buy) | 68,000 | - | - | Direct |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | Disposition Stock Option (Right to Buy) | 5,868 | - | - | Direct |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | Disposition Stock Option (Right to Buy) | 34,000 | - | - | Direct |
| May 21, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Exercise | 2,167 | - | - | Direct |
1-10 of 10 transactions